Description of Collaborative Activity: |
The International Neonatal Consortium (INC). INC is a coalition of industry, academia, patient representatives, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), other governmental agencies, professional organizations, foundations and the Critical Path Institute (C-Path) that will focus on accelerating the development of safe and effective treatments for neonates. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
